Vitamin K directly counteracts warfarin's anticoagulant effect. Large or inconsistent intake of vitamin K (from supplements or diet) can cause dangerous fluctuations in INR levels, potentially making warfarin either ineffective (increasing clot risk) or overly potent (increasing bleeding risk).
How This Interaction Works (Mechanism)
Warfarin works by inhibiting vitamin K epoxide reductase, the enzyme that recycles vitamin K. This reduces the availability of active vitamin K needed to produce clotting factors II, VII, IX, and X. When additional vitamin K is consumed, it provides substrate that bypasses warfarin's inhibition, restoring clotting factor production and reducing the anticoagulant effect.
Source: American Heart Association Warfarin Management Guidelines, 2025
The goal is consistency, not avoidance. Maintain a steady daily intake of vitamin K-containing foods (leafy greens, broccoli, Brussels sprouts). Do not take vitamin K supplements unless directed by your doctor. Avoid sudden large changes in your diet. Have your INR checked regularly and report any dietary changes to your anticoagulation clinic.
Check More Drug Interactions
Use our free interaction checker to search thousands of drug, supplement, and food combinations.
Open Interaction CheckerEveryday safety with a blood thinner
As an Amazon Associate I earn from qualifying purchases.
Sources and standards behind this page
What a drug interaction does, and how strongly it is supported, is documented in public labeling and federal safety references rather than in any one summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- DailyMed carries the current FDA labeling for every marketed drug product, including the warnings and drug interaction sections.
- Drugs@FDA is the federal database of approved drug products and their approval documents.
- FDA: Drug interactions, what you should know explains how drug-drug, drug-food and drug-condition interactions are described on labels.
- FDA Drug Safety Communications publishes the agency's safety alerts and label changes as they are issued.
- FDA MedWatch is the program for reporting and reviewing adverse events, including suspected interactions.
- openFDA provides public access to FDA labeling and adverse event data.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medicine is and how it is taken.
- NIAAA: Harmful interactions documents which medicines interact with alcohol and how.
- NCCIH: Herb-drug interactions summarises the evidence on interactions between herbal products and medicines.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how this interaction works and where it is documented. It is not medical advice: a prescriber or pharmacist decides what applies to a particular patient and medication.
Frequently Asked Questions
Warfarin and Vitamin K have a moderate interaction that requires caution. While some patients may take both under medical supervision, the combination can cause adverse effects. Talk to your doctor before combining these medications, and do not adjust doses on your own.
Vitamin K directly counteracts warfarin's anticoagulant effect. Large or inconsistent intake of vitamin K (from supplements or diet) can cause dangerous fluctuations in INR levels, potentially making warfarin either ineffective (increasing clot risk) or overly potent (increasing bleeding risk).
Yes. Anytime you are taking multiple medications, supplements, or substances, you should inform your doctor and pharmacist. They can evaluate your specific risk factors (age, kidney function, other medications, medical conditions) and determine whether the Warfarin and Vitamin K combination is safe for you, or whether adjustments are needed.
Related Resources
Get Drug Safety Alerts
Leave your email for updates on FDA warnings, new drug interactions, and patient safety information. We have not started sending yet, and we will only email when we do.